Haemonetics (HAE) stock forecast for 2026. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Haemonetics (HAE) stock forecast for 2026

Updated: July 17, 2024 (14:56)

Sector: Healthcare

The share price of Haemonetics Corporation (HAE) now

What analysts predict: $113.29
52-week High/Low: $97.97 / $70.74

50/200 Day Moving Average: $88.44 / $84.55

This figure corresponds to the Average Price over the previous 50/200 days. For Haemonetics stocks, the 50-day moving average is the resistance level today.

For Haemonetics stocks, the 200-day moving average is the resistance level today.

Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Haemonetics stock price in 2026. How much will one Haemonetics share be worth in 2026? Is it worth taking profit / loss on HAE stock now or waiting? What are analysts' forecasts for Haemonetics stock?

We forecast Haemonetics stock performance using neural networks based on historical data on HAE stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Haemonetics Corporation stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Haemonetics analysts is $113.29. Today 200 Day Moving Average is the resistance level (84.55 $). 50 Day Moving Average is the resistance level (88.44 $).




Historical and forecast chart of Haemonetics Corporation stock

The chart below shows the historical price of Haemonetics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the HAE stock price can be found in the table below.


Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.

Haemonetics (HAE) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 86.32 79.50 90.81 12.45 %
Feb 86.32 80.79 89.51 9.74 %
Mar 78.72 76.12 83.52 8.86 %
Apr 73.53 72.06 76.32 5.59 %
May 72.20 69.82 75.02 6.93 %
Jun 73.00 67.38 74.97 10.13 %
Jul 75.41 70.05 77.89 10.07 %
Aug 73.29 71.39 77.99 8.46 %
Sep 75.05 72.95 77.98 6.45 %
Oct 81.21 78.93 87.54 9.83 %
Nov 79.26 73.00 84.97 14.09 %
Dec 73.79 69.07 77.33 10.69 %

Haemonetics information and performance

Haemonetics Address

125 SUMMER STREET, BOSTON, MA, US

Market Capitalization: 4 664 756 000 $

Market capitalization of the Haemonetics Corporation is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of HAE shares in the company outstanding by the market price of one share.

EBITDA: 295 452 000 $

EBITDA of Haemonetics is earnings before interest, income tax and depreciation of assets.

PE Ratio: 39.98

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.633

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.29

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.298
Quarterly Revenue Growth YOY: 0.128
Trailing PE: 39.98

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 19.61

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.94

Enterprise Value (EV) /Revenue

EV To EBITDA: 18.98

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 50953000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Haemonetics price target for 2026 by month


Target values for the price of one Haemonetics share for Jan 2026.

The weighted average target price per Haemonetics share in Jan 2026 is: 86.32.
In Jan, the Positive dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 12.452% volatility is expected.
Pessimistic target level: 79.50
Optimistic target level: 90.81

Target values for the price of one Haemonetics share for Feb 2026.

The weighted average target price per Haemonetics share in Feb 2026 is: 86.32.
In Feb, the Negative dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 9.740% volatility is expected.
Pessimistic target level: 80.79
Optimistic target level: 89.51

Target values for the price of one Haemonetics share for Mar 2026.

The weighted average target price per Haemonetics share in Mar 2026 is: 78.72.
In Mar, the Negative dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 8.860% volatility is expected.
Pessimistic target level: 76.12
Optimistic target level: 83.52

Target values for the price of one Haemonetics share for Apr 2026.

The weighted average target price per Haemonetics share in Apr 2026 is: 73.53.
In Apr, the Negative dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 5.588% volatility is expected.
Pessimistic target level: 72.06
Optimistic target level: 76.32

Target values for the price of one Haemonetics share for May 2026.

The weighted average target price per Haemonetics share in May 2026 is: 72.20.
In May, the Negative dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 6.930% volatility is expected.
Pessimistic target level: 69.82
Optimistic target level: 75.02

Target values for the price of one Haemonetics share for Jun 2026.

The weighted average target price per Haemonetics share in Jun 2026 is: 73.00.
In Jun, the Positive dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 10.127% volatility is expected.
Pessimistic target level: 67.38
Optimistic target level: 74.97

Target values for the price of one Haemonetics share for Jul 2026.

The weighted average target price per Haemonetics share in Jul 2026 is: 75.41.
In Jul, the Positive dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 10.068% volatility is expected.
Pessimistic target level: 70.05
Optimistic target level: 77.89

Target values for the price of one Haemonetics share for Aug 2026.

The weighted average target price per Haemonetics share in Aug 2026 is: 73.29.
In Aug, the Negative dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 8.459% volatility is expected.
Pessimistic target level: 71.39
Optimistic target level: 77.99

Target values for the price of one Haemonetics share for Sep 2026.

The weighted average target price per Haemonetics share in Sep 2026 is: 75.05.
In Sep, the Positive dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 6.449% volatility is expected.
Pessimistic target level: 72.95
Optimistic target level: 77.98

Target values for the price of one Haemonetics share for Oct 2026.

The weighted average target price per Haemonetics share in Oct 2026 is: 81.21.
In Oct, the Positive dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 9.833% volatility is expected.
Pessimistic target level: 78.93
Optimistic target level: 87.54

Target values for the price of one Haemonetics share for Nov 2026.

The weighted average target price per Haemonetics share in Nov 2026 is: 79.26.
In Nov, the Negative dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 14.086% volatility is expected.
Pessimistic target level: 73.00
Optimistic target level: 84.97

Target values for the price of one Haemonetics share for Dec 2026.

The weighted average target price per Haemonetics share in Dec 2026 is: 73.79.
In Dec, the Negative dynamics for Haemonetics Corporation shares will prevail with possible monthly volatility of 10.687% volatility is expected.
Pessimistic target level: 69.07
Optimistic target level: 77.33



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.